日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Host response signatures across sepsis aetiologies in India: a single centre observational study

印度不同病因脓毒症的宿主反应特征:一项单中心观察性研究

Biemond, Jason J; Earny, Venkat A; Virk, Harjeet; Adukkadukkam, Anusree; Girish, Anjali; Klarenbeek, Augustijn M; Peters-Sengers, Hessel; Butler, Joe M; Mukhopadhyay, Chiranjay; Wiersinga, W Joost; van der Poll, Tom

Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)

在低收入和中等收入重症监护环境中揭示脓毒症流行病学,揭示热带感染和抗菌素耐药性的惊人负担:一项前瞻性观察研究(MARS-India)

Virk, Harjeet S; Biemond, Jason J; Earny, Venkat A; Chowdhury, Soumi; Frölke, Roos I; Khanna, Saachi M; Shanbhag, Vishal; Rao, Shwethapriya; Acharya, Raviraj V; Balakrishnan, Jayaraj M; Eshwara, Vandana K; Varma, Muralidhar D; van der Poll, Tom; Wiersinga, Willem J; Mukhopadhyay, Chiranjay

A Longitudinal Description of the Health-Related Quality of Life Among Individuals at High Risk After SARS-CoV-2 Infection: A Dutch Multicenter Observational Cohort Study

SARS-CoV-2感染后高危人群健康相关生活质量的纵向描述:一项荷兰多中心观察性队列研究

Vergouwe, Magda; Birnie, Emma; van Veelen, Sarah; Biemond, Jason J; Appelman, Brent; Peters-Sengers, Hessel; de Bree, Godelieve J; Popping, Stephanie; Wiersinga, W Joost

Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir for COVID-19 Among Individuals at High Risk: A Modeling Study

针对高危人群,使用尼马替韦/利托那韦治疗 COVID-19 的成本效益分析:一项建模研究

Birnie, Emma; Vergouwe, Magda; Appelman, Brent; Biemond, Jason J; Heijmans, Jarom; Nichols, Brooke E; Wiersinga, W Joost; Popping, Stephanie

A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals

针对严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 的强效特异性T细胞和B细胞反应与SARS-CoV-2 Omicron感染的免疫功能低下个体早期病毒清除相关

Vergouwe, Magda; Biemond, Jason J; van der Straten, Karlijn; van Pul, Lisa; Kerster, Gius; Claireaux, Mathieu; Burger, Judith A; van Dort, Karel A; Kootstra, Neeltje A; Jonges, Marcel; Welkers, Matthijs R A; Hazenberg, Mette D; Peters-Sengers, Hessel; van Gils, Marit J; Wiersinga, W Joost; Birnie, Emma; de Bree, Godelieve J

Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis

单克隆SARS-CoV-2抗体作为暴露前预防措施的健康结果和成本效益

Popping, Stephanie; Nichols, Brooke E; Appelman, Brent; Biemond, Jason J; Vergouwe, Magda; Rosendaal, Frits R; van der Valk, Marc; de Bree, Godelieve J; Wiersinga, W Joost; Birnie, Emma

Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant

在感染SARS-CoV-2 Omicron变异株的高危人群中,使用索托维单抗治疗后出现耐药相关突变

Birnie, Emma; Biemond, Jason J; Appelman, Brent; de Bree, Godelieve J; Jonges, Marcel; Welkers, Matthijs R A; Wiersinga, W Joost

Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.

新冠肺炎重症患者的肺部微生物群与持续性急性呼吸窘迫综合征相关

Kullberg Robert F J, de Brabander Justin, Boers Leonoor S, Biemond Jason J, Nossent Esther J, Heunks Leo M A, Vlaar Alexander P J, Bonta Peter I, van der Poll Tom, Duitman JanWillem, Bos Lieuwe D J, Wiersinga W Joost